Mesalazin
Følgende præparater indeholder indholdsstoffet
Mesalazin:
| Præparat | Dispenseringsform/styrke | Andre indholdsstoffer |
|---|---|---|
| Asacol® Tillotts | tabletter med modificeret udløsning 1600 mg (Tillotts) | |
| tabletter med modificeret udløsning 1600 mg (Tillotts) | ||
| enterotabletter 400 mg (Tillotts) | ||
| enterotabletter 800 mg (Tillotts) | ||
| enterotabletter 800 mg (Tillotts) | ||
| enterotabletter 800 mg (Tillotts) | ||
| enterotabletter 800 mg (Tillotts) | ||
| enterotabletter 800 mg (Tillotts) | ||
| suppositorier 1 g (Tillotts) | ||
| suppositorier 500 mg (Tillotts) | ||
| rektalvæske, suspension 1 g (Tillotts) | ||
| Mesalazin "2care4" Parallelimporteret | depottabletter 500 mg | |
| Mesalazin "Orion" Orion Pharma | enterotabletter 500 mg (Orion Pharma) | |
| enterotabletter 1000 mg (Orion Pharma) | ||
| suppositorier 1 g (Orion Pharma) | ||
| suppositorier 500 mg (Orion Pharma) | ||
| Mesavancol Parallelimporteret | enterodepottabletter 1200 mg | |
| enterodepottabletter 1200 mg | ||
| enterodepottabletter 1200 mg | ||
| Mezavant Takeda Pharma | enterodepottabletter 1200 mg (Takeda Pharma) | |
| Pentasa® Ferring | depottabletter 1 g (Ferring) | |
| depottabletter 1 g (Ferring) | ||
| depottabletter 1 g (Ferring) | ||
| depottabletter 1 g (Ferring) | ||
| depottabletter 500 mg (Ferring) | ||
| depotgranulat, endosis 1 g (Ferring) | ||
| depotgranulat, endosis 2 g (Ferring) | ||
| depotgranulat, endosis 2 g (Ferring) | ||
| depotgranulat, endosis 2 g (Ferring) | ||
| depotgranulat, endosis 4 g (Ferring) | ||
| depotgranulat, endosis 4 g (Ferring) | ||
| suppositorier 1 g (Ferring) | ||
| rektalvæske, suspension 1 g (Ferring) | ||
| Salofalk Vifor Pharma | enterodepotgranulat, breve 1,5 g (Vifor Pharma) | |
| enterodepotgranulat, breve 3 g (Vifor Pharma) | ||
| suppositorier 1 g (Vifor Pharma) | ||
| rektalskum 1 g (Vifor Pharma) | ||
| rektalvæske, suspension 4 g/60 ml (Vifor Pharma) |
